Literature DB >> 29244118

Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid.

Annagloria Palazzo1, Mattia Trunfio1, Veronica Pirriatore1, Maurizio Milesi1, Amedeo De Nicolò1, Chiara Alcantarini1, Antonio D'Avolio1, Stefano Bonora1, Giovanni Di Perri1, Andrea Calcagno1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29244118     DOI: 10.1093/jac/dkx461

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis.

Authors:  Dario Cattaneo; Sara Baldelli; Andrea Giacomelli; Davide Minisci; Paola Meraviglia; Noemi Astuti; Marta Fusi; Valeria Cozzi; Emilio Clementi; Massimo Galli; Cristina Gervasoni
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

Review 2.  Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?

Authors:  Vera E Bukkems; Angela Colbers; Catia Marzolini; Jose Molto; David M Burger
Journal:  Clin Pharmacokinet       Date:  2020-10       Impact factor: 6.447

Review 3.  Pharmacokinetic Considerations with the Use of Antiepileptic Drugs in Patients with HIV and Organ Transplants.

Authors:  Jorge J Asconapé
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-09       Impact factor: 5.081

4.  Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings.

Authors:  Dario Cattaneo; Salvatore Sollima; Paola Meraviglia; Laura Milazzo; Davide Minisci; Marta Fusi; Carlo Filice; Cristina Gervasoni
Journal:  Drugs R D       Date:  2020-06

Review 5.  Epilepsy management in pregnant HIV+ women in sub-Saharan Africa, clinical aspects to consider: a scoping review.

Authors:  Sonia Menon; Lenka Benova; Hillary Mabeya
Journal:  BMC Med       Date:  2020-11-17       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.